How many insider declarations has Thackray, Helen filed?

Thackray, Helen has filed 4 public insider declarations with SEDI.

What is Thackray, Helen's role?

Thackray, Helen's reported role is not specified by the regulator across the filings.

Which companies does Thackray, Helen report trades for?

Thackray, Helen reports trades for Eupraxia Pharmaceuticals Inc..

← Executives ★ Sign in to follow

TH

Thackray, Helen

·SEDI

Eupraxia Pharmaceuticals Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Browse the complete record of transactions filed by Thackray, Helen. Director active across 1 company, notably Eupraxia Pharmaceuticals Inc.. Aggregated, 4 disclosures have been recorded. History available since 13 July 2026. The latest transaction was filed on 13 July 2026 (50 - Grant of options). Regulator: SEDI. All data is openly available.

Companies and markets linked to Thackray, Helen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Eupraxia Pharmaceuticals Inc. (CA)

Declarations4 total

●

Thackray, Helen

4 - Director of IssuerExecutives13 Jul 2026Eupraxia Pharmaceuticals Inc.

0SEDI ↗

20,000 sharesRights Restricted Stock UnitTSXSEDI:4754031

●

Thackray, Helen

4 - Director of IssuerExecutives3 Jul 2026Eupraxia Pharmaceuticals Inc.

0SEDI ↗

Rights Restricted Stock UnitTSXSEDI:4754030

◇

Thackray, Helen

4 - Director of IssuerExecutives13 Jul 2026Eupraxia Pharmaceuticals Inc.

CA$378,4000SEDI ↗

40,000 shares@ CA$9.46OptionsTSXSEDI:4754029

●

Thackray, Helen

4 - Director of IssuerExecutives3 Jul 2026Eupraxia Pharmaceuticals Inc.

0SEDI ↗

OptionsTSXSEDI:4754028

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

TH

Thackray, Helen

·SEDI

Eupraxia Pharmaceuticals Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

0

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Browse the complete record of transactions filed by Thackray, Helen. Director active across 1 company, notably Eupraxia Pharmaceuticals Inc.. Aggregated, 4 disclosures have been recorded. History available since 13 July 2026. The latest transaction was filed on 13 July 2026 (50 - Grant of options). Regulator: SEDI. All data is openly available.